CN Patent

CN103459373B — 制备喹啉化合物的方法和含有所述化合物的药物组合物

Assigned to Exelixis Inc · Expires 2018-02-23 · 8y expired

What this patent protects

本发明涉及制备例如式I的喹啉或其药学上可接受的盐的方法和含有所述喹啉或其药学上可接受的盐的组合物，其中：X1是H、Br、CI，或X2是H、Br、CI，或n1是1‑2；并且n2是1‑2。

USPTO Abstract

本发明涉及制备例如式I的喹啉或其药学上可接受的盐的方法和含有所述喹啉或其药学上可接受的盐的组合物，其中：X1是H、Br、CI，或X2是H、Br、CI，或n1是1‑2；并且n2是1‑2。

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: CN103459373B
Jurisdiction: CN
Classification: —
Expires: 2018-02-23
Drug substance claim: No
Drug product claim: No
Assignee: Exelixis Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.